"Formularies as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about lists of drugs or collections of recipes, formulas, and prescriptions for the compounding of medicinal preparations. Formularies differ from PHARMACOPOEIAS in that they are less complete, lacking full descriptions of the drugs, their formulations, analytic composition, chemical properties, etc. In hospitals, formularies list all drugs commonly stocked in the hospital pharmacy.
Descriptor ID |
D005569
|
MeSH Number(s) |
L01.178.682.192.836.535
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Formularies as Topic".
Below are MeSH descriptors whose meaning is more specific than "Formularies as Topic".
This graph shows the total number of publications written about "Formularies as Topic" by people in this website by year, and whether "Formularies as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Formularies as Topic" by people in Profiles.
-
Neumann PJ, Lin PJ, Greenberg D, Berger M, Teutsch S, Mansley E, Weinstein MC, Rosen AB. Do drug formulary policies reflect evidence of value? Am J Manag Care. 2006 Jan; 12(1):30-6.
-
Briesacher B, Kamal-Bahl S, Hochberg M, Orwig D, Kahler KH. Three-tiered-copayment drug coverage and use of nonsteroidal anti-inflammatory drugs. Arch Intern Med. 2004 Aug 9-23; 164(15):1679-84.
-
Kamal-Bahl S, Briesacher B. How do incentive-based formularies influence drug selection and spending for hypertension? Health Aff (Millwood). 2004 Jan-Feb; 23(1):227-36.
-
Andrade SE, Gurwitz JH, Cernieux J, Fish LS. Evaluation of a formulary switch from conjugated to esterified estrogens in a managed care setting. Med Care. 2000 Sep; 38(9):970-5.
-
Gurwitz JH, McLaughlin TJ, Fish LS. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products. Health Serv Res. 1995 Dec; 30(5):672-85.